PDCD1 and neoplasm: Furthermore, CTLA-4 and PD-1 expression in peripheral blood and tumor-infiltrating lymphocytes increases with immune checkpoint inhibition, reflecting the expansion of effector T-cell populations that would otherwise have been apoptotic or dysfunctional.